Other languages BiVictriX Therapeutics plc

Equities

BVX

GB00BNXH3K91

Market Closed - London S.E. Other stock markets 09:05:00 28/06/2024 pm IST			5-day change	1st Jan Change
12.5 ^GBX	0.00%		0.00%	+19.05%

21/06	BiVictriX Therapeutics Plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI
13/06	EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss	AN

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BiVictriX Therapeutics Plc Reports Earnings Results for the Full Year Ended December 31, 2023	21/06
EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss	14/06
BiVictriX Therapeutics' Leukemia Treatment Shows Favorable Safety Profile	13/06
BiVictriX Therapeutics Plc Announces Compelling Safety Profile of BVX001 in Pre-Clinical Models Supports Progression to Clinic	13/06
EARNINGS AND TRADING: CT UK High Income tops benchmark, ups dividend	31/05
Bivictrix granted FDA orphan drug status for rare cancer treatment	17/04
Bivictrix Therapeutics plc Announces Resignation of Iain Ross from the Board	05/12
Bivictrix selects final sequences for lead tumour programme	30/11
BiVictriX Therapeutics plc Announces Pipeline Update on Lead Solid Tumour Programme, Bvx002	30/11
BiVictriX patent boost; 4Global deal extended	15/11
BiVictriX Obtains Japanese Patent for Acute Myeloid Leukemia Drug Conjugate	15/11
Bivictrix Therapeutics Says Patent Granted In Japan Providing Further Broad Protection For BVX001	15/11
Bivictrix says BVX001 increases survival rates by more than double	12/23/12
Bivictrix Therapeutics PLC Extended Survival Rates Reported With Bvx001 In A Pre-Clinical Model Of Acute Myeloid Leukaemia	12/23/12
Bivictrix hires new CFO as Alex Hughes steps down after seven months	03/23/03
BiVictriX Therapeutics Plc Appoints Adrian Howd as Chief Business Officer	03/23/03
AEW UK REIT appoints new chair; Oberon raises money	19/23/19
BiVictriX Therapeutics Plc Reports Earnings Results for the Half Year Ended June 30, 2023	19/23/19
AIM WINNERS & LOSERS: Jadestone Energy up on Montara repairs progress	23/23/23
Bivictrix Therapeutics granted US patent for cancer drug BVX001	23/23/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages BiVictriX Therapeutics plc

Equities

BVX

GB00BNXH3K91

Other languages

Filters